InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
2.040
0.00 (0.00%)
Nov 21, 2024, 11:19 AM EST - Market open

InflaRx Revenue

InflaRx had revenue of 123.82K EUR in the quarter ending September 30, 2024, with 103.64% growth. This brings the company's revenue in the last twelve months to 168.50K, up 177.12% year-over-year. In the year 2023, InflaRx had annual revenue of 63.09K.

Revenue (ttm)
168.50K EUR
Revenue Growth
+177.12%
P/S Ratio
n/a
Revenue / Employee
2,709 EUR
Employees
62
Market Cap
120.12M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202363.09K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Seres Therapeutics 126.33M
TELA Bio 68.65M
Journey Medical 57.77M
Fennec Pharmaceuticals 49.35M
Cidara Therapeutics 44.65M
Adlai Nortye 5.00M
Century Therapeutics 2.68M
Revenue Rankings